Women's Health Initiative touts ROI

Share this article:

The NIH-backed Women's Health Initiative (WHI) reported a financial analysis of data from one of its postmenopausal hormone therapy trials, noting that each dollar received “results in a return of $140 in net economic value for each dollar invested in the trial.”

Results of the trial, called the Postmenopausal Hormone Therapy Trial, were published in 2002. But its long-term financial and health outcomes appeared yesterday in the Annals of Internal Medicine.

The ROI assessment was based on a disease simulation model which found that the guidance provided by WHI clinical trial results translated to 76,000 fewer cases of cardiovascular disease, 4.3 million fewer combined hormone therapy users, 126,000 breast cancer cases, 145,000 more quality-adjusted life-years, and direct medical expenditure savings of $35.2 billion.

However, the analysis also found that the guidance provided by the WHI clinical trial results led to 263,000 more fractures (hip, vertebral, and other osteoporotic bones).

The researchers calculated the total net economic return of the trial, which cost $260 million in inflation-adjusted dollars, at $37.1 billion.

The WHI has tracked women since 1993.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.